Yu-Rong Gu
Overview
Explore the profile of Yu-Rong Gu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
113
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cai M, Chen D, Chen X, Gu Y, Liao C, Xiao L, et al.
Cell Oncol (Dordr)
. 2024 Jul;
47(5):1897-1910.
PMID: 39080215
Background: Liver cancer stem cells (CSCs) contribute to tumor initiation, progression, and recurrence in hepatocellular carcinoma (HCC). The Wnt/β-catenin pathway plays a crucial role in liver cancer stemness, progression, metastasis,...
2.
Zhang X, Li S, Gu Y, Xiao L, Ma X, Chen X, et al.
Mol Cancer
. 2024 May;
23(1):113.
PMID: 38802795
Background: The role of circRNAs in hepatocellular carcinoma (HCC) progression remains unclear. CircPIAS1 (circBase ID: hsa_circ_0007088) was identified as overexpressed in HCC cases through bioinformatics analysis. This study aimed to...
3.
Cai M, Chen D, Xiao L, Li S, Liao C, Li J, et al.
Lab Invest
. 2023 Mar;
103(7):100130.
PMID: 36925047
Collectin subfamily member 10 (COLEC10), a C-type lectin mainly expressed in the liver, is involved in the development of hepatocellular carcinoma (HCC). However, its underlying molecular mechanism in HCC progression...
4.
Wu L, Li X, Deng H, Xie D, Gu Y, Bi Y, et al.
Virus Res
. 2021 Dec;
309:198657.
PMID: 34919970
Background: The relationship between the serum transforming growth factor (TGF)-β level and HBsAg loss has not been clearly elaborated in patients with chronic hepatitis B (CHB). Methods: Two cohorts of...
5.
Lian Y, Xu Y, Gu Y, Bi Y, Liao C, Zhao M, et al.
Liver Int
. 2020 Jun;
40(11):2672-2684.
PMID: 32564486
Background & Aims: T-cell receptor (TCR) repertoire is ambiguously changed in chronic hepatitis B (CHB) patients during antivirus therapy. We tried to assess TCR repertoire dynamics and its clinical significance...
6.
Huang Y, Ning G, Chen L, Lian Y, Gu Y, Wang J, et al.
Cancer Manag Res
. 2019 Mar;
11:1725-1740.
PMID: 30863181
Background: A growing body of evidence suggests that E2Fs, by regulating gene expression related to cell cycle progression and other cellular processes, play a pivotal role in human cancer. However,...
7.
Zhu H, Gu Y, Zhang G, Su Y, Wang K, Zheng Y, et al.
Exp Ther Med
. 2016 Jun;
12(1):405-409.
PMID: 27347069
Depression in patients with chronic hepatitis B (CHB) can affect the quality of life, disease diagnosis and case fatality rate. The aim of this study was to explore depression in...
8.
Shi Q, Luo J, Wu K, Yin M, Gu Y, Cheng X
Oncotarget
. 2016 Jan;
7(8):9007-16.
PMID: 26789112
Accumulating evidences indicate the elevated expression of αB-Crystallin (Cryab) is implicated in tumorigenesis. However, the expression and biologic role of Cryab in osteosarcoma (OS) are still unknown. In this study,...
9.
Zheng Y, Gu Y, Zhang M, Wang K, Huang Z, Lin C, et al.
BMC Infect Dis
. 2015 Nov;
15:542.
PMID: 26590815
Backgrounds: Health-care workers' (HCWs) exposure to bodily fluids puts them at risk of hepatitis B virus HBV infection. This study investigated HBV vaccination practices and outcomes in HCWs and assessed...
10.
Peng L, Liu J, Li Y, Huang Z, Wang P, Gu Y, et al.
Exp Ther Med
. 2013 Nov;
6(5):1169-1176.
PMID: 24223640
The aim of this study was to analyze the changes in serum protein levels in the progression of hepatitis B using isobaric tags for relative and absolute quantitation (iTRAQ) analysis,...